Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

The emergence of new biologics for severe asthma.

Eger KA, Bel EH.

Curr Opin Pharmacol. 2019 Jun;46:108-115. doi: 10.1016/j.coph.2019.05.005. Epub 2019 Jun 21. Review.

PMID:
31229937
2.

A dedicated diribonucleotidase resolves a key bottleneck for the terminal step of RNA degradation.

Kim SK, Lormand JD, Weiss CA, Eger KA, Turdiev H, Turdiev A, Winkler WC, Sondermann H, Lee VT.

Elife. 2019 Jun 21;8. pii: e46313. doi: 10.7554/eLife.46313.

3.

Farm dust reduces viral load in human bronchial epithelial cells by increasing barrier function and antiviral responses.

van der Vlugt LEPM, Eger K, Müller C, Ninaber DK, Zarcone MC, Amatngalim GD, Bracher F, von Mutius E, Smits HH, Hiemstra PS.

J Allergy Clin Immunol. 2018 May;141(5):1949-1952.e8. doi: 10.1016/j.jaci.2018.01.025. Epub 2018 Feb 7. No abstract available.

PMID:
29425849
4.

Occupational exposure to trichloroethylene and cancer risk for workers at the Paducah Gaseous Diffusion Plant.

Bahr DE, Aldrich TE, Seidu D, Brion GM, Tollerud DJ; Paducah Gaseous Diffusion Plant Project Team, Muldoon S, Reinhart N, Youseefagha A, McKinney P, Hughes T, Chan C, Rice C, Brewer DE, Freyberg RW, Mohlenkamp AM, Hahn K, Hornung R, Ho M, Dastidar A, Freitas S, Saman D, Ravdal H, Scutchfield D; Contractors, Eger KJ, Minor S.

Int J Occup Med Environ Health. 2011 Mar;24(1):67-77. doi: 10.2478/s13382-011-0007-1. Epub 2011 Feb 16.

5.

Camptocormia phenotype of FSHD: a clinical and MRI study on six patients.

Jordan B, Eger K, Koesling S, Zierz S.

J Neurol. 2011 May;258(5):866-73. doi: 10.1007/s00415-010-5858-z. Epub 2010 Dec 17.

PMID:
21165637
6.

Organisierte, qualitätsgesicherte Brustkrebsfrüherkennung: Herausforderungen und Erfolge des Wiener Mammographiemodellprojektes «Ich schau auf mich».

Wimmer-Puchinger B, Eger K, Helbich T.

Breast Care (Basel). 2009 Nov;4(5):342-343. doi: 10.1159/000242501. Epub 2009 Oct 21. No abstract available.

7.

Airway epithelial cells as guardians of immune homeostasis?

Brodlie M, Eger K, Hilkens CM, Ward C.

Thorax. 2009 Nov;64(11):1009. doi: 10.1136/thx.2009.120121. No abstract available.

PMID:
19864551
8.

Beevor's sign in facioscapulohumeral muscular dystrophy: an old sign with new implications.

Eger K, Jordan B, Habermann S, Zierz S.

J Neurol. 2010 Mar;257(3):436-8. doi: 10.1007/s00415-009-5342-9. Epub 2009 Oct 17.

PMID:
19838767
9.

Prioritising integrated care initiatives on a national level. Experiences from Austria.

Eger K, Gleichweit S, Rieder A, Stein KV.

Int J Integr Care. 2009 Sep 17;9:e91.

10.

Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial.

Strothotte S, Strigl-Pill N, Grunert B, Kornblum C, Eger K, Wessig C, Deschauer M, Breunig F, Glocker FX, Vielhaber S, Brejova A, Hilz M, Reiners K, Müller-Felber W, Mengel E, Spranger M, Schoser B.

J Neurol. 2010 Jan;257(1):91-7. doi: 10.1007/s00415-009-5275-3. Epub 2009 Aug 1.

PMID:
19649685
11.

Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis.

Fernández-Santiago R, Hoenig S, Lichtner P, Sperfeld AD, Sharma M, Berg D, Weichenrieder O, Illig T, Eger K, Meyer T, Anneser J, Münch C, Zierz S, Gasser T, Ludolph A.

J Neurol. 2009 Aug;256(8):1337-42. doi: 10.1007/s00415-009-5124-4. Epub 2009 Apr 12.

12.

[Polymyositis associated with thymoma].

Jordan B, Eger K, Zierz S.

Nervenarzt. 2009 Jun;80(6):708-11. doi: 10.1007/s00115-009-2689-1. German.

PMID:
19347264
13.

4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin.

Gebhardt R, Lerche KS, Götschel F, Günther R, Kolander J, Teich L, Zellmer S, Hofmann HJ, Eger K, Hecht A, Gaunitz F.

J Cell Mol Med. 2010 Jun;14(6A):1276-93. doi: 10.1111/j.1582-4934.2009.00701.x. Epub 2009 Oct 3.

14.

Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells.

Ward C, Eger K, Diboll J, Jones D, Haniffa MA, Brodlie M, Fisher A, Lordan JL, Corris PA, Hilkens CM.

Thorax. 2009 May;64(5):430-5. doi: 10.1136/thx.2008.104067. Epub 2009 Jan 21.

15.

Distinct muscle imaging patterns in myofibrillar myopathies.

Fischer D, Kley RA, Strach K, Meyer C, Sommer T, Eger K, Rolfs A, Meyer W, Pou A, Pradas J, Heyer CM, Grossmann A, Huebner A, Kress W, Reimann J, Schröder R, Eymard B, Fardeau M, Udd B, Goldfarb L, Vorgerd M, Olivé M.

Neurology. 2008 Sep 2;71(10):758-65. doi: 10.1212/01.wnl.0000324927.28817.9b.

16.

Molecular diagnosis of German patients with late-onset glycogen storage disease type II.

Joshi PR, Gläser D, Schmidt S, Vorgerd M, Winterholler M, Eger K, Zierz S, Deschauer M.

J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S261-5. doi: 10.1007/s10545-008-0820-2. Epub 2008 Jul 10.

PMID:
18607768
17.

[Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].

Jordan B, Eger K, Kornhuber ME, Zierz S.

Fortschr Neurol Psychiatr. 2008 Jan;76(1):21-7. doi: 10.1055/s-2007-993032. Review. German.

PMID:
18189220
18.

Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients.

Kley RA, Hellenbroich Y, van der Ven PF, Fürst DO, Huebner A, Bruchertseifer V, Peters SA, Heyer CM, Kirschner J, Schröder R, Fischer D, Müller K, Tolksdorf K, Eger K, Germing A, Brodherr T, Reum C, Walter MC, Lochmüller H, Ketelsen UP, Vorgerd M.

Brain. 2007 Dec;130(Pt 12):3250-64. Review.

PMID:
18055494
20.

Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions.

Eger KA, Sundrud MS, Motsinger AA, Tseng M, Van Kaer L, Unutmaz D.

PLoS One. 2006 Dec 20;1:e50.

22.

Lactate production upon short-term non-ischemic forearm exercise in mitochondrial disorders and other myopathies.

Hanisch F, Eger K, Bork S, Lehnich H, Deschauer M, Zierz S.

J Neurol. 2006 Jun;253(6):735-40. Epub 2006 Apr 20.

PMID:
16619130
23.

MuSK-antibody positive pure ocular myasthenia gravis.

Hanisch F, Eger K, Zierz S.

J Neurol. 2006 May;253(5):659-60. Epub 2005 Nov 29. No abstract available.

PMID:
16311895
24.

Only subtle cognitive deficits in non-bulbar amyotrophic lateral sclerosis patients.

Röttig D, Leplow B, Eger K, Ludolph AC, Graf M, Zierz S.

J Neurol. 2006 Mar;253(3):333-9. Epub 2005 Oct 10.

PMID:
16208524
25.

Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells.

Sundrud MS, Vancompernolle SE, Eger KA, Bruno TC, Subramaniam A, Mummidi S, Ahuja SK, Unutmaz D.

Blood. 2005 Nov 15;106(10):3440-8. Epub 2005 Aug 9.

26.

The innate immune system and HIV pathogenesis.

Eger KA, Unutmaz D.

Curr HIV/AIDS Rep. 2005 Feb;2(1):10-5. Review.

PMID:
16091243
27.

High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.

Graf M, Ecker D, Horowski R, Kramer B, Riederer P, Gerlach M, Hager C, Ludolph AC, Becker G, Osterhage J, Jost WH, Schrank B, Stein C, Kostopulos P, Lubik S, Wekwerth K, Dengler R, Troeger M, Wuerz A, Hoge A, Schrader C, Schimke N, Krampfl K, Petri S, Zierz S, Eger K, Neudecker S, Traufeller K, Sievert M, Neundörfer B, Hecht M; German vitamin E/ALS Study Group.

J Neural Transm (Vienna). 2005 May;112(5):649-60. Epub 2004 Oct 27.

PMID:
15517433
28.

Synthesis and biological evaluation of new derivatives of emodin.

Teich L, Daub KS, Krügel V, Nissler L, Gebhardt R, Eger K.

Bioorg Med Chem. 2004 Nov 15;12(22):5961-71.

PMID:
15498672
29.

4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models.

Eger K, Hermes M, Uhlemann K, Rodewald S, Ortwein J, Brulport M, Bauer AW, Schormann W, Lupatsch F, Schiffer IB, Heimerdinger CK, Gebhard S, Spangenberg C, Prawitt D, Trost T, Zabel B, Sauer C, Tanner B, Kolbl H, Krugel U, Franke H, Illes P, Madaj-Sterba P, Bockamp EO, Beckers T, Hengstler JG.

Biochem Biophys Res Commun. 2004 Oct 22;323(3):979-86.

PMID:
15381096
30.

Perturbation of natural killer cell function and receptors during HIV infection.

Eger KA, Unutmaz D.

Trends Microbiol. 2004 Jul;12(7):301-3.

PMID:
15223055
31.

Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.

Ng SS, MacPherson GR, Gütschow M, Eger K, Figg WD.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4192-7.

32.

Apoptosis by 6-O-palmitoyl-L-ascorbic acid coincides with JNK-phosphorylation and inhibition of Mg2+-dependent phosphatase activity.

Kaap S, Brechlin P, Quentin I, Eger K, Steinfelder HJ.

Biochem Pharmacol. 2004 Mar 1;67(5):919-26.

PMID:
15104245
33.

Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors.

Lepper ER, Ng SS, Gütschow M, Weiss M, Hauschildt S, Hecker TK, Luzzio FA, Eger K, Figg WD.

J Med Chem. 2004 Apr 22;47(9):2219-27.

PMID:
15084120
34.

Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.

Krasnianski M, Eger K, Neudecker S, Jakubiczka S, Zierz S.

Arch Neurol. 2003 Oct;60(10):1421-5.

PMID:
14568813
35.

Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.

Krasnianski M, Neudecker S, Eger K, Jakubiczka S, Zierz S.

J Neurol. 2003 Sep;250(9):1084-7.

PMID:
14504970
36.

Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues.

Ng SS, Gütschow M, Weiss M, Hauschildt S, Teubert U, Hecker TK, Luzzio FA, Kruger EA, Eger K, Figg WD.

Cancer Res. 2003 Jun 15;63(12):3189-94.

38.

[Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].

Krasnianski M, Neudecker S, Eger K, Schulte-Mattler W, Zierz S.

Nervenarzt. 2003 Feb;74(2):151-8. German.

PMID:
12596016
39.

Structure activity analysis of the pro-apoptotic, antitumor effect of nitrostyrene adducts and related compounds.

Kaap S, Quentin I, Tamiru D, Shaheen M, Eger K, Steinfelder HJ.

Biochem Pharmacol. 2003 Feb 15;65(4):603-10.

PMID:
12566088
40.

Cytokine modulation and suppression of liver injury by a novel analogue of thalidomide.

Thiele A, Bang R, Gütschow M, Rossol M, Loos S, Eger K, Tiegs G, Hauschildt S.

Eur J Pharmacol. 2002 Oct 25;453(2-3):325-34.

PMID:
12398921
41.

Michael adducts of palmitoylascorbic acid: effects on the oxidative burst of neutrophils and the production of tumor necrosis factor-alpha in monocytes.

Gütschow M, Hauschildt S, Benard S, Reichl S, Witt UG, Eger K, Arnhold J.

Pharmacology. 2002 Nov;66(3):162-8.

PMID:
12372906
42.

Profiling indomethacin impurities using high-performance liquid chromatography and nuclear magnetic resonance.

Hess S, Teubert U, Ortwein J, Eger K.

Eur J Pharm Sci. 2001 Dec;14(4):301-11.

PMID:
11684404
43.

[Progressive limb-girdle muscular dystrophy].

Eger K, Zierz S.

Dtsch Med Wochenschr. 2001 Jun 1;126(22):655-8. Review. German. No abstract available.

PMID:
11450625
44.

Synthesis and immunological activity of water-soluble thalidomide prodrugs.

Hess S, Akermann MA, Wnendt S, Zwingenberger K, Eger K.

Bioorg Med Chem. 2001 May;9(5):1279-91.

PMID:
11377186
45.

Rapid and sensitive LC separation of new impurities in trimethoprim.

Hess S, Akermann M, Ropte D, Eger K.

J Pharm Biomed Anal. 2001 Jun;25(3-4):531-8.

PMID:
11377033
46.

Aza analogues of thalidomide: synthesis and evaluation as inhibitors of tumor necrosis factor-alpha production in vitro.

Gütschow M, Hecker T, Thiele A, Hauschildt S, Eger K.

Bioorg Med Chem. 2001 Apr;9(4):1059-65.

PMID:
11354662
47.

Separation, analyses and syntheses of trimethoprim impurities.

Hess S, Dölker M, Haferburg D, Kertscher HP, Matysik FM, Ortwein J, Teubert U, Zimmermann W, Eger K.

Pharmazie. 2001 Apr;56(4):306-10.

PMID:
11338669
48.

Effect of an adenosine A(1) receptor agonist and a novel pyrimidoindole on membrane properties and neurotransmitter release in rat cortical and hippocampal neurons.

Eschke D, Brand A, Scheibler P, Hess S, Eger K, Allgaier C, Nieber K.

Neurochem Int. 2001 Apr;38(5):391-8.

PMID:
11222919
49.

7-Deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists.

Hess S, Müller CE, Frobenius W, Reith U, Klotz KN, Eger K.

J Med Chem. 2000 Nov 30;43(24):4636-46.

PMID:
11101355
50.

A possible role of N-cadherin in thalidomide teratogenicity.

Thiele A, Thormann M, Hofmann HJ, Naumann WW, Eger K, Hauschildt S.

Life Sci. 2000 Jun 16;67(4):457-61.

PMID:
11003055

Supplemental Content

Support Center